Mass General Brigham, one of the nation's largest health systems, has discovered that the most successful AI deployments aren't about the technology itself—they're about solving real business problems with human oversight at the center. According to Jane Moran, chief information and digital officer at the Boston-based organization, the difference between AI initiatives that succeed and those that stall comes down to one fundamental question: What problem are you actually trying to solve? Why Most Organizations Get AI Strategy Wrong? When Moran is asked about Mass General Brigham's AI strategy, her answer surprises many executives: "For us, our AI strategy is our business strategy." This isn't corporate jargon. It reflects a hard-won lesson from managing AI deployment across nearly 80,000 employees spread across more than 15 hospitals, including two world-class academic medical centers. The health system regularly hears the same request from departments: "Can we just have a little AI on the side?" That question reveals the core problem. Too many organizations treat AI as a separate initiative—a shiny new tool to bolt onto existing operations. Mass General Brigham learned that approach wastes resources and creates confusion. Instead, the organization now asks: What measurable business outcome are we trying to achieve? This shift in thinking has led to a disciplined focus. Rather than saying yes to every AI opportunity, Mass General Brigham has deliberately said no to many proposals over the past several months. The organization now concentrates its efforts on just four strategic areas: - Clinical Care: Using AI to enhance diagnostics and support clinical decision-making while maintaining human accountability - Patient Access: Streamlining how patients interact with the health system and access services - Research: Accelerating discovery and improving data analysis to shorten the path from insight to impact - Employee Productivity: Enabling the workforce to focus on higher-value work by automating routine tasks Each use case is tied to measurable impact. The organization tracks whether AI is improving outcomes, accelerating innovation, strengthening operational performance, or enabling employees to do more meaningful work. How to Build Responsible AI Governance Across Your Organization Mass General Brigham's journey reveals that scaling AI safely requires far more than just deploying models. The health system has implemented a comprehensive governance framework that other enterprises can learn from: - Mandatory Training Programs: Anyone who wants to use AI in the organization must complete training. The health system is now exploring making certain training mandatory for specific roles, even though this isn't regulatory-mandated—it's considered the responsible approach - Secure Internal Platform: The organization built an internal "AI Zone," a secure, multi-model prompt platform that gives all employees access to approved large language models, AI assistants, and agents while protecting sensitive health information and personally identifiable data - Risk Assessment Framework: Before deploying any AI tool, the organization accounts for patient safety, bias in data, unintended disparities in decision-making, and cybersecurity risks, recognizing that AI tools increase exposure to sensitive data and broaden the attack surface - Formal Governance Process: As recently as 2024, Mass General Brigham relied on existing technology governance frameworks for AI. By 2025, the organization recognized the need for a formal, dedicated AI governance process to manage the rapid expansion of AI use cases "Safely and effectively scaling AI depends on people and process as much as actual models and the technology," Moran explained. "It's about building a sustainable, human-centered AI capability that drives meaningful outcomes across the enterprise." What Happens When You Move AI From Pilots to Enterprise Deployment? Mass General Brigham's experience with ambient documentation—using AI to create patient visit notes—illustrates both the opportunity and the complexity of enterprise-scale AI deployment. The health system started with a single clinical use case and brought the capability to a small group of clinicians. The response was immediate and enthusiastic. Clinicians loved the tool, and requests grew rapidly. The pilot eventually enrolled over 1,000 people. But success created new challenges. The organization discovered that many staff members were already using AI tools on their own—tools that weren't always compliant with organizational standards or security requirements. This revealed a critical gap: the need for enterprise-wide guidance, governance, and education. The health system also learned that researchers across multiple disciplines were using AI for cancer research, Alzheimer's studies, lung cancer imaging, and more. Many were relying on public-facing consumer AI tools for their research, which posed risks around data security and compliance. This discovery prompted the creation of the AI Zone platform, giving researchers and all employees a safe, secure way to use AI with protected health information and sensitive business data. The lesson here is stark: moving from pilots to enterprise deployment requires more than just scaling up. Organizations need the right technology foundations, workforce education, high-quality data, regulatory alignment, and operational integration. Without these elements, successful pilots often fail to translate into sustainable enterprise capabilities. The Human Element: Why AI Augments Rather Than Replaces Throughout its AI journey, Mass General Brigham has maintained one consistent principle: responsible use. This means AI must be ethical, equitable, productivity-focused, and quality-driven—with human oversight and support at every stage. "AI supports decision-making and enhances diagnostics, but it always augments rather than replaces professional judgment," Moran emphasized. "Human accountability remains central." This philosophy reflects the high-stakes nature of healthcare, where AI errors can have serious consequences. But the principle applies broadly across industries: AI works best when it enhances human capability rather than attempting to replace human judgment entirely. The organization approaches AI deployment with deliberate caution. "In healthcare, we're approaching it with caution because of the high stakes involved," Moran noted. "We need to take care of our patients, our researchers and our employees." This cautious approach doesn't mean moving slowly—Mass General Brigham carried out numerous proofs of concept and pilots throughout 2024. Rather, it means being intentional about which problems AI should solve and how to implement solutions responsibly. For enterprises considering their own AI transformation, the message from Mass General Brigham is clear: AI strategy is business strategy. Success requires aligning AI initiatives with measurable business outcomes, building governance structures that prioritize safety and transparency, investing in workforce education, and maintaining human oversight at every stage. The technology matters, but the people and processes matter more.
